JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 39.40
+0.12 (0.31%)
Jul 31, 2026, 4:08 PM HKT
JD Health International Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 125,668 | 178,115 | 89,880 | 124,675 | 226,887 | 196,309 | |
Market Cap Growth | -21.85% | 98.17% | -27.91% | -45.05% | 15.58% | -58.90% |
Enterprise Value | 72,794 | 124,562 | 38,636 | 70,956 | 173,601 | 146,144 |
Last Close Price | 39.40 | 55.50 | 28.10 | 39.10 | 71.35 | 61.45 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.07 | 29.78 | 20.29 | 52.84 | 528.00 | - |
Forward PE | 15.67 | 24.37 | 17.60 | 26.41 | 67.40 | 112.32 |
PS Ratio | 1.54 | 2.18 | 1.45 | 2.11 | 4.29 | 5.21 |
PB Ratio | 1.88 | 2.66 | 1.53 | 2.29 | 4.48 | 4.01 |
P/TBV Ratio | 1.94 | 2.75 | 1.59 | 2.40 | 4.72 | 4.01 |
P/FCF Ratio | 11.27 | 15.97 | 19.71 | 24.91 | 34.22 | 54.61 |
P/OCF Ratio | 11.10 | 15.73 | 19.50 | 24.58 | 33.99 | 46.62 |
PEG Ratio | 1.56 | 1.76 | 1.35 | 0.96 | 1.31 | 10.11 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.89 | 1.52 | 0.62 | 1.20 | 3.29 | 3.88 |
EV/EBITDA Ratio | 16.30 | 28.16 | 27.61 | 81.02 | - | - |
EV/EBIT Ratio | 17.52 | 29.47 | 31.22 | 102.10 | - | - |
EV/FCF Ratio | 6.53 | 11.17 | 8.47 | 14.18 | 26.18 | 40.66 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
Debt / EBITDA Ratio | 0.16 | 0.16 | 0.19 | 0.25 | - | - |
Debt / FCF Ratio | 0.06 | 0.06 | 0.06 | 0.05 | 0.03 | 0.07 |
Net Debt / Equity Ratio | -0.79 | -0.79 | -0.92 | -0.83 | -1.06 | -1.05 |
Net Debt / EBITDA Ratio | -11.95 | -11.95 | -38.77 | -51.59 | 779.12 | 30.47 |
Net Debt / FCF Ratio | -4.74 | -4.74 | -11.89 | -9.02 | -8.09 | -14.27 |
Asset Turnover | 0.96 | 0.96 | 0.86 | 0.85 | 0.86 | 0.67 |
Inventory Turnover | 8.70 | 8.70 | 8.21 | 7.52 | 8.15 | 9.84 |
Quick Ratio | 2.38 | 2.38 | 3.38 | 2.89 | 3.04 | 5.30 |
Current Ratio | 2.72 | 2.72 | 3.77 | 3.28 | 3.45 | 5.71 |
Return on Equity (ROE) | 9.31% | 9.31% | 7.95% | 4.55% | 0.91% | -2.71% |
Return on Assets (ROA) | 3.11% | 3.11% | 1.07% | 0.63% | -0.17% | -1.91% |
Return on Invested Capital (ROIC) | 26.92% | 40.19% | 15.96% | 17.69% | - | - |
Return on Capital Employed (ROCE) | 6.20% | 6.20% | 2.10% | 1.30% | -0.30% | -3.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.76% | 3.36% | 4.93% | 1.89% | 0.19% | -0.67% |
FCF Yield | 8.88% | 6.26% | 5.08% | 4.01% | 2.92% | 1.83% |
Buyback Yield / Dilution | -1.14% | -1.14% | 0.12% | -0.62% | -1.60% | -40.13% |